🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

4 recruiting trials

for Lymphoma Patients With High-risk of Central Nervous System Relapse

ASCT With TEAM Conditioning for Lymphoma With High Risk of CNS Relapse NCT07481669Phase 21 site📍 Hangzhou Second Affiliated Hospital, Zhejiang University, School of … · Tests: TEAM regimen (thiotepa, etoposide, cytarabine and melphalan) Acalabrutinib Maintenance for the Treatment of Patients With Large B-cell Lymphoma NCT05256641Phase 1, Phase 23 sites📍 Los Angeles📍 Sacramento📍 Oklahoma City Jonsson Comprehensive Cancer Center · Tests: Acalabrutinib A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma NCT06736613Phase 27 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: Cerebral Spinal Fluid ctDNA R-CDOP Combined With Intrathecal Methotrexate for DLBCL Patients With High-risk of CNS Relapse NCT05257018Phase 22 sites📍 Shanghai📍 Ürümqi Fudan University · Tests: R-CDOP+intrathecal MTX
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy